Thursday, June 13, 2024 11:14:38 AM
Trying? You did.
“I'm saying that from a scientific standpoint, the evidence for a reduction in opioid use in that study is not going to convince the CMS to approve RecoveryRx for reimbursement under the NOPAIN Act.”
Agree…as I posted before…
“…What CMS will or will not accept is another matter. No one knows. I would think that the noted study would not suffice; not robust….”
Yet, that does not mean the results were insignificant given the one patient outlier event pushed at the expense of all the other patients for whom BIEL’s product showed amazing efficacy with opioid reduction.
Lastly…agree…good time to take a breather.
All imo.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM